ACUTE KIDNEY INJURY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH ONE DOSE OF NIVOLUMAB : CASE REPORT

被引：0
|
作者：
Jangam, Kadambari [1 ]
Huston, Hunter [2 ]
机构：
[1] UPMC Mckeesport Hosp program, McKeesport, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
84
引用
收藏
页码：S24 / S25
页数：2
相关论文
共 50 条
  • [21] Primary tumor resection after nivolumab treatment for metastatic renal cell carcinoma: A case report
    Tanegashima, Tokiyoshi
    Tsukahara, Shigehiro
    Ikenoue, Takashi
    Otsubo, Satoshi
    Hasehawa, Shuji
    Nishikawa, Hiroyoshi
    Eto, Masatoshi
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
    Go Noguchi
    Sohgo Tsutsumi
    Masato Yasui
    Shinji Ohtake
    Susumu Umemoto
    Noboru Nakaigawa
    Masahiro Yao
    Takeshi Kishida
    BMC Urology, 18
  • [23] Complete response to perioperative treatment using nivolumab for metastatic renal cell carcinoma: A case report
    Ikarashi, Daiki
    Nakamura, Yasuyuki
    Shimodate, Hitoshi
    Usui, Yoshitaka
    Ujiie, Takashi
    Ohara, Wataru
    UROLOGY CASE REPORTS, 2019, 24
  • [24] Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
    Noguchi, Go
    Tsutsumi, Sohgo
    Yasui, Masato
    Ohtake, Shinji
    Umemoto, Susumu
    Nakaigawa, Noboru
    Yao, Masahiro
    Kishida, Takeshi
    BMC UROLOGY, 2018, 18
  • [25] Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
    Masaki Murata
    Yohei Ikeda
    Go Hasegawa
    Yuki Nakagawa
    Tsutomu Nishiyama
    Journal of Medical Case Reports, 13
  • [26] Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
    Murata, Masaki
    Ikeda, Yohei
    Hasegawa, Go
    Nakagawa, Yuki
    Nishiyama, Tsutomu
    JOURNAL OF MEDICAL CASE REPORTS, 2019, 13 (01)
  • [27] Nivolumab-induced celiac-like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature
    Duval, Lucie
    Habes, Sarah
    Chatellier, Thierry
    Guerzider, Pascale
    Bossard, Celine
    Masliah, Claude
    Archambeaud, Isabelle
    Touchefeu, Yann
    Matysiak-Budnik, Tamara
    CLINICAL CASE REPORTS, 2019, 7 (09): : 1689 - 1693
  • [28] Dose Matters: The Importance of Appropriate Dosing: A Case Report on Sunitinib Treatment in a Patient With Metastatic Renal Cell Carcinoma
    Bojic, Marija
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 277 - 279
  • [29] Changes of TCR repertoire in metastatic renal cell carcinoma and metastatic melanoma patients treated with nivolumab
    Klabusay, M.
    Skacel, J.
    Coupek, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Nivolumab/paclitaxel/ramucirumabLack of efficacy and acute kidney injury: case report
    Reactions Weekly, 2022, 1937 (1) : 376 - 376
12345